CCX 4503
Alternative Names: CCX4503Latest Information Update: 01 Dec 2022
At a glance
- Originator ChemoCentryx
- Class Antineoplastics; Small molecules
- Mechanism of Action Immunologic cytotoxicity; Programmed cell death 1 receptor antagonists; Programmed cell death-1 ligand-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours